Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors

J Neuroimmunol. 2023 Jan 15:374:578009. doi: 10.1016/j.jneuroim.2022.578009. Epub 2022 Dec 5.

Abstract

Central nervous system (CNS) tumors are the most common type of solid tumors in children and the leading cause of cancer deaths in ages 0-14. Recent advances in the field of tumor biology and immunology have underscored the disparate nature of these distinct CNS tumor types. In this review, we briefly introduce pediatric CNS tumors and discuss various components of the TME, with a particular focus on myeloid cells. Although most studies regarding myeloid cells have been done on adult CNS tumors and animal models, we discuss the role of myeloid cell heterogeneity in pediatric CNS tumors and describe how these cells may contribute to tumorigenesis and treatment response. In addition, we present studies within the last 5 years that highlight human CNS tumors, the utility of various murine CNS tumor models, and the latest multi-dimensional tools that can be leveraged to investigate myeloid cell infiltration in young adults and children diagnosed with select CNS tumors.

Keywords: CNS tumors; Glioma; Myeloid cells; Single cell RNA sequencing.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Animals
  • Central Nervous System / pathology
  • Central Nervous System Neoplasms* / therapy
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Infant, Newborn
  • Mice
  • Myeloid Cells / metabolism
  • Tumor Microenvironment*